Description

Ambroxol (Ambroxol Hydrochloride) Tablets 0.03g. №20

Ingredients

Each tablet contains 0.03g of Ambroxol hydrochloride as the active ingredient.

Mechanism of Action

Ambroxol is a mucolytic agent that works by breaking down and thinning mucus in the airways, facilitating expectoration and improving respiratory function.

Pharmacological Properties

Ambroxol stimulates surfactant production in the lungs, enhancing lung elasticity and exerting antioxidant effects to protect against oxidative stress in the respiratory system.

Indications for Use

Ambroxol tablets are indicated for the treatment of respiratory diseases characterized by excessive and thick mucus secretion, such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD).

Contraindications

Ambroxol tablets should not be administered to individuals with a known hypersensitivity to Ambroxol hydrochloride or any other components of the formulation.

Side Effects

Common side effects of Ambroxol tablets include gastrointestinal disturbances such as nausea, vomiting, or abdominal discomfort. Adverse reactions are usually mild and transient.

Usage Instructions

For adults and children over 12 years old, the recommended dosage is one tablet (0.03g) taken orally three times daily. Tablets should be swallowed whole with an adequate amount of water, without crushing or chewing.

Benefits Compared to Analogues

Ambroxol has demonstrated comparable efficacy to other mucolytic agents in clinical studies, with the added advantage of antioxidant properties that may provide additional respiratory protection.

Suitable Patient Groups

Ambroxol tablets are suitable for use in both adult and pediatric populations, including elderly patients, under appropriate medical supervision.

Storage and Shelf Life

Store Ambroxol tablets in a cool, dry place away from direct sunlight. Ensure proper sealing of the packaging to protect from moisture. Check the expiration date and do not use expired products.

Packaging Description

Ambroxol tablets are typically packaged in blister packs of 20 tablets each, ensuring individual tablet integrity and facilitating convenient dosing.

Clinical Evidence and Proven Effectiveness

Clinical studies have shown that Ambroxol is effective in improving mucus clearance, reducing respiratory symptoms, and enhancing lung function in patients with various respiratory conditions. A comparative study published in the Journal of Pulmonary Pharmacology confirmed the therapeutic value of Ambroxol in managing chronic respiratory diseases.